<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Peacock, W. Frank</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Current Perspectives on Biomarkers in AHF</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-32</style></pages><abstract><style  face="normal" font="default" size="100%">Heart failure phenotypes are currently categorized in various ways (eg, as acute vs chronic disease) or by the disease consequences. This article explores the role of some promising new biomarkers as novel approaches to define and treat acute heart failure phenotypes.</style></abstract><number><style face="normal" font="default" size="100%">42</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>